As emerging from the data presented in this review, Lactoferrin, and especially its bovine milk derivative form, is potentially a strong candidate for anti-cancer alternative treatment with the same advantages but almost null side effects characterizing standard therapies. This evidence concerns the gene LTF and cancer.